Page last updated: 2024-08-24

arctigenin and Carcinoma, Non-Small Cell Lung

arctigenin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SH; Lou, Z; Xu, Y1
Jin, JJ; Wang, HQ; Wang, J1

Other Studies

2 other study(ies) available for arctigenin and Carcinoma, Non-Small Cell Lung

ArticleYear
Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
    Biochemical and biophysical research communications, 2017, 11-18, Volume: 493, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Asteraceae; beta Catenin; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Furans; Humans; Lignans; Lung; Lung Neoplasms; Neoplasm Invasiveness; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta

2017
Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
    Journal of biochemical and molecular toxicology, 2014, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Base Sequence; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA Primers; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Furans; Humans; Inhibitor of Apoptosis Proteins; Lignans; Lung Neoplasms; Polymerase Chain Reaction; Survivin

2014